Renin angiotensin system (RAS) antagonists, angiotensin-converting enzyme (ACE)
inhibitors, and angiotensin II receptor antagonists are increasingly used to treat …

OBJECTIVE: To review current literature relating to the adverse effects of the angiotensin-
converting enzyme (ACE) inhibitors. DATA SOURCES: Online drug information sources …

Angiotensin-converting enzyme inhibitors (ACEIs) are increasingly used in the treatment of
cardiovascular disease, but recent reports have warned of some hemodynamic risk …

Enalapril, an angiotensin converting enzyme (ACE) inhibitor usually administered orally
once daily, decreases blood pressure by lowering peripheral vascular resistance without …

The use of captopril in heart failure and hypertension is becoming increasingly accepted.
Captopril has a sulphydryl group in its molecular structure. We wondered if this might confer …

We previously demonstrated that captopril (CP) exhibited a high ability to inhibit
enzymatically generated leukotrienes, particularly LTB4, from stimulated intact human …

Fifteen patients presented between January 1986 and January 1991 with deterioration in
renal function coincident with the introduction of angiotensin converting enzyme inhibitors …

Three pathways are critically involved in blood pressure regulation during anaesthesia, ie
the sympathetic nervous system, the renin angiotensin system (RAS), and the …

A variety of antihypertensive drugs have been introduced into clinical practice at excessively
high dose. Examples include most thiazide diuretics, propranolol, oxprenolol, atenolol …

Quinapril HCl is a novel, nonsulf hydryl angiotensin-converting en zyme (ACE) inhibitor. The
Study Group evaluated its efficacy (20, 40, 80 mg daily with forced dose titration …